PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Broccoli sprout extract promising for head and neck cancer prevention

2015-04-19
(Press-News.org) PHILADELPHIA, April 19, 2015 - Broccoli sprout extract protects against oral cancer in mice and proved tolerable in a small group of healthy human volunteers, the University of Pittsburgh Cancer Institute (UPCI), partner with UPMC CancerCenter, announced today at the American Association for Cancer Research (AACR) Annual Meeting in Philadelphia.

The promising results will be further explored in a human clinical trial, which will recruit participants at high risk for head and neck cancer recurrence later this year. This research is funded through Pitt's Specialized Program of Research Excellence grant in head and neck cancer from the National Cancer Institute.

"People who are cured of head and neck cancer are still at very high risk for a second cancer in their mouth or throat, and, unfortunately, these second cancers are commonly fatal," said lead author Julie Bauman, M.D., M.P.H., co-director of the UPMC Head and Neck Cancer Center of Excellence. "So we're developing a safe, natural molecule found in cruciferous vegetables to protect the oral lining where these cancers form."

Previous studies, including large-scale trials in China, have shown that cruciferous vegetables that have a high concentration of sulforaphane - such as broccoli, cabbage and garden cress - help mitigate the effects of environmental carcinogens.

Dr. Bauman collaborated with Daniel E. Johnson, Ph.D., professor of medicine at Pitt and a senior scientist in the UPCI Head and Neck Cancer Program, to test sulforaphane in the laboratory. For several months, Dr. Johnson and his team gave sulforaphane to mice predisposed to oral cancer and found that it significantly reduced the incidence and number of tumors.

"The clear benefit of sulforaphane in preventing oral cancer in mice raises hope that this well-tolerated compound also may act to prevent oral cancer in humans who face chronic exposure to environmental pollutants and carcinogens," said Dr. Johnson.

Dr. Bauman treated 10 healthy volunteers with fruit juice mixed with sulforaphane-rich broccoli sprout extract. The volunteers had no ill-effects from the extract and protective changes were detectable in the lining of their mouths, meaning it was absorbed and directed to at-risk tissue.

These findings were enough to prompt a clinical trial that will recruit 40 volunteers who have been curatively treated for head and neck cancer. The participants will regularly take capsules containing broccoli seed powder to determine if they can tolerate the regimen and whether it has enough of an impact on their oral lining to prevent cancer. From there, larger clinical trials could be warranted.

"We call this 'green chemoprevention,' where simple seed preparations or plant extracts are used to prevent disease," said Dr. Bauman, also an associate professor in Pitt's School of Medicine. "Green chemoprevention requires less money and fewer resources than a traditional pharmaceutical study, and could be more easily disseminated in developing countries where head and neck cancer is a significant problem."

INFORMATION:

Additional authors on this research are Yan Zhang, Ph.D., Malabika Sen, Ph.D., Daniel P. Normolle, Ph.D., Thomas W. Kensler, Ph.D., Sumita Trivedi, M.B.B.S., and Siddharth H. Sheth, D.O., M.P.H., all of Pitt; Jennifer R. Grandis, M.D., F.A.C.S., of Pitt at the time the research was conducted; and Patricia A. Egner, M.S., of Johns Hopkins University.

About UPCI As the only NCI-designated comprehensive cancer center in western Pennsylvania, UPCI is a recognized leader in providing innovative cancer prevention, detection, diagnosis, and treatment; bio-medical research; compassionate patient care and support; and community-based outreach services. Investigators at UPCI, a partner with UPMC CancerCenter, are world-renowned for their work in clinical and basic cancer research.

http://www.upmc.com/media



ELSE PRESS RELEASES FROM THIS DATE:

Seeking new targets for ovarian cancer treatment

2015-04-19
PHILADEPHIA, April 19, 2015 - Identifying molecular changes that occur in tissue after chemotherapy could be crucial in advancing treatments for ovarian cancer, according to research from Magee-Womens Research Institute and Foundation (MWRIF) and the University of Pittsburgh Cancer Institute (UPCI), partner with UPMC CancerCenter, presented today at the American Association for Cancer Research (AACR) Annual Meeting 2015. For years now, intraperitoneal chemotherapy, a treatment which involves filling the abdominal cavity with chemotherapy drugs after surgery, has been ...

Investigational personalized cellular therapy tolerated well by patients

2015-04-19
PHILADELPHIA -Genetically modified versions of patients' own immune cells successfully traveled to tumors they were designed to attack in an early-stage trial for mesothelioma and pancreatic and ovarian cancers at the Perelman School of Medicine at the University of Pennsylvania. The data adds to a growing body of research showing the promise of CAR T cell technology. The interim results will be presented at the American Association for Cancer Research (AACR) Annual Meeting 2015, April 18-22. "The goal of this phase I trial was to study the safety and feasibility of ...

Literacy app improves school readiness in at-risk preschoolers

2015-04-19
Using mobile apps in preschool classrooms may help improve early literacy skills and boost school readiness for low-income children, according to research by NYU's Steinhardt School of Culture, Education, and Human Development. "Guided use of an educational app may be a source of motivation and engagement for children in their early years," said Susan B. Neuman, professor of childhood and literacy education at NYU Steinhardt and the study's author. "The purpose of our study was to examine if a motivating app could accelerate children's learning, which it did." Neuman ...

Schools must track academic progress of homeless students, researchers argue

2015-04-19
Schools must track the academic progress of homeless students with as much care as they track special education, Title I and English language learner students, according to researchers at University of the Pacific. "In an age of accountability, schools focus their efforts and attention on the students they are mandated to report on," said Ronald Hallett, associate professor of education and lead author of the study. "We need to realign our policies and procedures if we are going to improve academic outcomes for homeless and highly mobile students." Hallett and his colleagues ...

NYU study evaluates the influence of college experiences on career outcomes

2015-04-18
Meaningful college experiences, including internships and studying abroad, may not matter as much as your major and what school you attend when it comes to job satisfaction and earnings, according to research by NYU's Steinhardt School of Culture, Education, and Human Development. "Our study adds important nuance to our understanding of the influence specific college experiences have on economic and attitudinal job outcomes in the years following college graduation," said Gregory Wolniak, director of the Center for Research on Higher Education Outcomes at NYU Steinhardt ...

Study reveals a cause of poorer outcomes for African-American patients with breast cancer

2015-04-18
PHILADELPHIA --Poorer outcomes for African-American women with estrogen-receptor positive (ER+) breast cancer, compared with European-American patients, appears to be due, in part, to a strong survival mechanism within the cancer cells, according to a study being presented at the American Association for Cancer Research (AACR) Annual Meeting 2015. Georgetown Lombardi Comprehensive Cancer Center investigators report that breast tumors from African-American patients show reduced sensitivity to tamoxifen, a leading treatment for ER+ breast cancer, caused by increased activation ...

Potential migraine therapy to be presented April 22 by Achelios Therapeutics

2015-04-18
Chapel Hill, N.C., April 17, 2015 - Achelios Therapeutics will announce results from a Phase IIa placebo-controlled clinical trial in moderate and severe migraine sufferers treated with TOPOFEN (TM), the company's proprietary topical anti-migraine therapy. The data to be presented demonstrate that the simple application of a well-known non-steroidal anti-inflammatory drug (NSAID), using the company's proprietary formulation on the skin, over the trigeminal nerve branches, can be a safe and effective alternative treatment for patients suffering from acute migraine. William ...

New research shows how to tackle obesity

2015-04-18
Study shows there are six different types of obese people Treating individuals according to which 'type' could be more effective Targeted strategies would also mean a more efficient use of NHS services One size does not fit all when it comes to tackling obesity, according to a new study by the University of Sheffield. Researchers looking at how to tackle the country's obesity issue - which costs the NHS £6billion pounds every year* - found that currently individuals are often treated the same regardless of how healthy they are, where they live or their ...

New Notre Dame paper opens the door to the study of a new class of materials

2015-04-17
A new paper by a team of researchers led by Karel Matous, College of Engineering Associate Professor of Computational Mechanics in the Department of Aerospace and Mechanical Engineering at the University of Notre Dame, describes how an accurate statistical description of heterogeneous particulate materials, which is used within statistical micromechanics theories, governs the overall thermo-mechanical properties. This detailed statistical description was computed using a novel adaptive interpolation/integration scheme on the nation's largest parallel supercomputers. Quantifying ...

Researchers make key malarial drug-resistence finding

2015-04-17
According to the World Health Organization's 2014 World Malaria Report, there are an estimated 198 million cases of malaria worldwide with 3.3 billion people at risk for contracting the infection. Although the impact of malaria is still significant, the statistics reflect a considerable reduction in the global malaria burden. Since 2010, disease transmission has been reduced by 30 percent and mortality due to malaria has decreased by almost half. Artemisinins are powerful drugs that have the most rapid action of all current drugs against Plasmodium falciparum, the parasite ...

LAST 30 PRESS RELEASES:

Label distribution similarity-based noise correction for crowdsourcing

The Lancet: Without immediate action nearly 260 million people in the USA predicted to have overweight or obesity by 2050

Diabetes medication may be effective in helping people drink less alcohol

US over 40s could live extra 5 years if they were all as active as top 25% of population

Limit hospital emissions by using short AI prompts - study

UT Health San Antonio ranks at the top 5% globally among universities for clinical medicine research

Fayetteville police positive about partnership with social workers

Optical biosensor rapidly detects monkeypox virus

New drug targets for Alzheimer’s identified from cerebrospinal fluid

Neuro-oncology experts reveal how to use AI to improve brain cancer diagnosis, monitoring, treatment

Argonne to explore novel ways to fight cancer and transform vaccine discovery with over $21 million from ARPA-H

Firefighters exposed to chemicals linked with breast cancer

Addressing the rural mental health crisis via telehealth

Standardized autism screening during pediatric well visits identified more, younger children with high likelihood for autism diagnosis

Researchers shed light on skin tone bias in breast cancer imaging

Study finds humidity diminishes daytime cooling gains in urban green spaces

Tennessee RiverLine secures $500,000 Appalachian Regional Commission Grant for river experience planning and design standards

AI tool ‘sees’ cancer gene signatures in biopsy images

Answer ALS releases world's largest ALS patient-based iPSC and bio data repository

2024 Joseph A. Johnson Award Goes to Johns Hopkins University Assistant Professor Danielle Speller

Slow editing of protein blueprints leads to cell death

Industrial air pollution triggers ice formation in clouds, reducing cloud cover and boosting snowfall

Emerging alternatives to reduce animal testing show promise

Presenting Evo – a model for decoding and designing genetic sequences

Global plastic waste set to double by 2050, but new study offers blueprint for significant reductions

Industrial snow: Factories trigger local snowfall by freezing clouds

Backyard birds learn from their new neighbors when moving house

New study in Science finds that just four global policies could eliminate more than 90% of plastic waste and 30% of linked carbon emissions by 2050

Breakthrough in capturing 'hot' CO2 from industrial exhaust

New discovery enables gene therapy for muscular dystrophies, other disorders

[Press-News.org] Broccoli sprout extract promising for head and neck cancer prevention